These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23648748)

  • 1. Impact of overactive bladder treatment on the quality of life of patients over 60 with associated pathologies.
    Espuña-Pons M; Castro-Díaz D; Díaz-Cuervo H; Pérez M
    Arch Esp Urol; 2013 Apr; 66(3):287-94. PubMed ID: 23648748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of overactive bladder treatment on associated comorbidities].
    Espuña-Pons M; Castro-Díaz D; Díaz-Cuervo H; Pérez M
    Actas Urol Esp; 2012; 36(10):590-6. PubMed ID: 22365078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden.
    Peeker R; Samsioe G; Kowalski J; Andersson AS; Bergqvist A
    Scand J Urol Nephrol; 2010 Apr; 44(3):138-46. PubMed ID: 20367449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
    Herschorn S; Staskin D; Tu LM; Fialkov J; Walsh T; Gooch K; Schermer CR
    Health Qual Life Outcomes; 2018 Apr; 16(1):69. PubMed ID: 29673355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of urinary incontinence and overactive bladder syndrome on health-related quality of life of working middle-aged patients and institutionalized elderly patients].
    Martínez Agulló E; Ruíz Cerdá JL; Gómez Pérez L; Rebollo P; Pérez M; Chaves J
    Actas Urol Esp; 2010 Mar; 34(3):242-50. PubMed ID: 20416241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Health-Related Quality of Life is Influenced by Nocturia and Sleep Disturbance: Investigation Based on the SF-8.
    Suekane S; Ueda K; Suyama S; Hayashi T; Toyozawa N; Yoshitake M; Nishihara K; Sakashita N; Uchimura N; Matsuoka K
    Kurume Med J; 2016; 62(1-2):9-16. PubMed ID: 26935441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic status and health-related quality of life among adults and older with overactive bladder.
    Kosilov K; Loparev S; Kuzina I; Kosilova L; Prokofyeva A
    Int J Qual Health Care; 2019 May; 31(4):289-297. PubMed ID: 30107414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.
    Lee KS; Yoo TK; Liao L; Wang J; Chuang YC; Liu SP; Chu R; Sumarsono B
    BMC Urol; 2017 Nov; 17(1):108. PubMed ID: 29162085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life.
    Reisch R; Rutt R; Dockter M; Sanders S
    J Womens Health (Larchmt); 2018 Feb; 27(2):156-161. PubMed ID: 28953429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Solifenacin on Generic and Symptom-Specific Quality of Life for Females with Overactive Bladder: Using the Overactive Bladder Symptom Score and Rand Medical Outcomes Study 36-Item Health Survey.
    Yano M; Suzuki H; Kamiya N; Kato T; Nomura K; Kuramochi H; Ohta S; Mikami K; Nakatsu H; Okano T; Onishi T; Ichikawa T
    Low Urin Tract Symptoms; 2013 Jan; 5(1):5-10. PubMed ID: 26663241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial.
    Fowler CJ; Auerbach S; Ginsberg D; Hale D; Radziszewski P; Rechberger T; Patel VD; Zhou J; Thompson C; Kowalski JW
    Eur Urol; 2012 Jul; 62(1):148-57. PubMed ID: 22464310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of overactive bladder questionnaire (1-week recall version) in medically complex elderly patients with overactive bladder.
    Barsdorf AI; Carlsson M; Bushmakin AG; Quinn S; Cappelleri JC; Pleil A
    Int Urogynecol J; 2017 Dec; 28(12):1857-1863. PubMed ID: 28378111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder.
    Oh SJ; Ku JH; Choo MS; Yun JM; Kim DY; Park WH
    Int J Urol; 2008 Jan; 15(1):62-7; discussion 67. PubMed ID: 18184175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.